Search results for CD144

PE/Cyanine7 anti-mouse CD144 VE-cadherin Antibody anti-CD144 - BV13, BioLegend, 138015
Clone BV13 recognizes an epitope between aa 45 and 56, and has a binding affinity of 5-15 nM5. Additional reported applications (for relevant formats) include: Western blotting1, blocking of cell interactionsin vivo1, and immunofluorescence microscopystaining4.
Host
Rat
Reactivity
Mouse
Applications
FC - Quality tested
Conjugation

PE/Cyanine7 anti-mouse CD144 VE-cadherin Antibody anti-CD144 - BV13, BioLegend, 138016
Clone BV13 recognizes an epitope between aa 45 and 56, and has a binding affinity of 5-15 nM5. Additional reported applications (for relevant formats) include: Western blotting1, blocking of cell interactionsin vivo1, and immunofluorescence microscopystaining4.
Host
Rat
Reactivity
Mouse
Applications
FC - Quality tested
Conjugation

TotalSeq™-A1036 anti-mouse CD144 (VE-cadherin) Antibody, CD144, BV13, BioLegend, 138017
Clone BV13 recognizes an epitope between aa 45 and 56, and has a binding affinity of 5-15 nM5. Additional reported applications (for relevant formats) include: Western blotting1, blocking of cell interactionsin vivo1, and immunofluorescence microscopystaining4.
Host
Rat
Reactivity
Mouse
Applications
PG -Quality tested
Conjugation

TotalSeq™-C1036 anti-mouse CD144 (VE-cadherin) Antibody, CD144, BV13, BioLegend, 138021
Clone BV13 recognizes an epitope between aa 45 and 56, and has a binding affinity of 5-15 nM5. Additional reported applications (for relevant formats) include: Western blotting1, blocking of cell interactionsin vivo1, and immunofluorescence microscopystaining4.
Host
Rat
Reactivity
Mouse
Applications
PG - Quality tested
Conjugation

PE/Cyanine7 anti-human CD144 (VE-Cadherin) Antibody anti-CD144 - BV9, BioLegend, 348515
Clone BV9 has been shown to block VE-cadherin, causing a redistribution of VE-cadherin away from intracellular junctions.6This clone binds to EC3-EC4 region in the extracellular domain of human VE-cadherin.7Additional reported applications (for the relevant formats) include: Western Blotting1,2, immunofluorescence microscopy1,3, immunoprecipitation1,4, blocking angiogenesisin vitro4,5, inhibiting VE-cadherin reorganization4, and inducing endothelial cell apoptosis4.
Host
Mouse
Reactivity
Human
Applications
FC -Quality tested
Conjugation

PE/Cyanine7 anti-human CD144 (VE-Cadherin) Antibody anti-CD144 - BV9, BioLegend, 348516
Clone BV9 has been shown to block VE-cadherin, causing a redistribution of VE-cadherin away from intracellular junctions.6This clone binds to EC3-EC4 region in the extracellular domain of human VE-cadherin.7Additional reported applications (for the relevant formats) include: Western Blotting1,2, immunofluorescence microscopy1,3, immunoprecipitation1,4, blocking angiogenesisin vitro4,5, inhibiting VE-cadherin reorganization4, and inducing endothelial cell apoptosis4.
Host
Mouse
Reactivity
Human
Applications
FC -Quality tested
Conjugation

PerCP/Cyanine5.5 anti-human CD144 VE-Cadherin Antibody anti-CD144 - BV9, BioLegend, 348509
Clone BV9 has been shown to block VE-cadherin, causing a redistribution of VE-cadherin away from intracellular junctions.6This clone binds to EC3-EC4 region in the extracellular domain of human VE-cadherin.7Additional reported applications (for the relevant formats) include: Western Blotting1,2, immunofluorescence microscopy1,3, immunoprecipitation1,4, blocking angiogenesisin vitro4,5, inhibiting VE-cadherin reorganization4, and inducing endothelial cell apoptosis4.
Host
Mouse
Reactivity
Human
Applications
FC - Quality tested
Conjugation

PerCP/Cyanine5.5 anti-human CD144 VE-Cadherin Antibody anti-CD144 - BV9, BioLegend, 348510
Clone BV9 has been shown to block VE-cadherin, causing a redistribution of VE-cadherin away from intracellular junctions.6This clone binds to EC3-EC4 region in the extracellular domain of human VE-cadherin.7Additional reported applications (for the relevant formats) include: Western Blotting1,2, immunofluorescence microscopy1,3, immunoprecipitation1,4, blocking angiogenesisin vitro4,5, inhibiting VE-cadherin reorganization4, and inducing endothelial cell apoptosis4.
Host
Mouse
Reactivity
Human
Applications
FC - Quality tested
Conjugation

TotalSeq™-C0400 anti-human CD144 VE-Cadherin Antibody, CD144, BV9, BioLegend, 348521
Clone BV9 has been shown to block VE-cadherin, causing a redistribution of VE-cadherin away from intracellular junctions.6This clone binds to EC3-EC4 region in the extracellular domain of human VE-cadherin.7Additional reported applications (for the relevant formats) include: Western Blotting1,2, immunofluorescence microscopy1,3, immunoprecipitation1,4, blocking angiogenesisin vitro4,5, inhibiting VE-cadherin reorganization4, and inducing endothelial cell apoptosis4.
Host
Mouse
Reactivity
Human
Applications
PG -Quality tested
Conjugation

TotalSeq™-B0400 anti-human CD144 (VE-Cadherin) Antibody, CD144, BV9, BioLegend, 348523
Clone BV9 has been shown to block VE-cadherin, causing a redistribution of VE-cadherin away from intracellular junctions.6This clone binds to EC3-EC4 region in the extracellular domain of human VE-cadherin.7Additional reported applications (for the relevant formats) include: Western Blotting1,2, immunofluorescence microscopy1,3, immunoprecipitation1,4, blocking angiogenesisin vitro4,5, inhibiting VE-cadherin reorganization4, and inducing endothelial cell apoptosis4.
Host
Mouse
Reactivity
Human
Applications
PG - Quality tested
Conjugation
Please provide the required information below so that we can quickly source your products.
